Ocular Therapeutix (OCUL) EBT Margin (QoQ) (2014 - 2026)

Ocular Therapeutix (OCUL) EBT Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ocular Therapeutix 1.93 Bn 1.93 Bn 9.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -32,593.00
Dec 31, 2025 -4,184.00
Sep 30, 2025 3,196.00
Jun 30, 2025 9,029.00
Mar 31, 2025 -30,268.00
Dec 31, 2024 -446.00
Sep 30, 2024 -3,460.00
Jun 30, 2024 2,737.00
Mar 31, 2024 -9,237.00
Dec 31, 2023 -4,077.00
Sep 30, 2023 155.00
Jun 30, 2023 3,397.00
Mar 31, 2023 -6,172.00
Dec 31, 2022 7,680.00
Sep 30, 2022 -1,710.00
Jun 30, 2022 -2,774.00
Mar 31, 2022 1,239.00
Dec 31, 2021 1,403.00
Sep 30, 2021 1,243.00
Jun 30, 2021 11,151.00